MoonLake Immunotherapeutics, (MLTX): Price and Financial Metrics

MoonLake Immunotherapeutics, (MLTX): $49.82

0.49 (+0.99%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add MLTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#317 of 332

in industry

MLTX Price/Volume Stats

Current price $49.82 52-week high $64.98
Prev. close $49.33 52-week low $37.55
Day low $48.97 Volume 191,000
Day high $50.98 Avg. volume 371,624
50-day MA $50.03 Dividend yield N/A
200-day MA $46.90 Market Cap 3.18B

MLTX Stock Price Chart Interactive Chart >


MoonLake Immunotherapeutics, (MLTX) Company Bio


MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.


MLTX Latest News Stream


Event/Time News Detail
Loading, please wait...

MLTX Latest Social Stream


Loading social stream, please wait...

View Full MLTX Social Stream

MLTX Price Returns

1-mo 3.79%
3-mo 0.10%
6-mo 21.96%
1-year 9.95%
3-year 403.23%
5-year N/A
YTD -17.50%
2023 475.14%
2022 6.17%
2021 -13.02%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!